Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis

Heart

Volumn 103, Issue 10, 2017, Pages 774-782

  Dumitrescu, Daniel ^a   Nagel, Christian ^b,c   Kovacs, Gabor ^d   Bollmann, Tom ^e   Halank, Michael ^f   Winkler, Jörg ^g   Hellmich, Martin ^h   Grünig, Ekkehard ^b   Olschewski, Horst ^d   Ewert, Ralf ^e   Rosenkranz, Stephan ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Klinikum Mittelbaden   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY OF GREIFSWALD   (Germany)

^f UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^g UNIVERSITY OF LEIPZIG   (Germany)

^h UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART CATHETERIZATION; HEART OUTPUT; HEART VENTRICLE PRESSURE; HUMAN; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; SYSTEMIC SCLEROSIS; TOTAL LUNG CAPACITY; AGED; ALGORITHM; CLINICAL TRIAL; COMPLICATION; EXERCISE TEST; FOLLOW UP; HEART RIGHT VENTRICLE FUNCTION; HYPERTENSION, PULMONARY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SCLERODERMA, SYSTEMIC; VASCULAR RESISTANCE;

AGED; ALGORITHMS; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SCLERODERMA, SYSTEMIC; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, RIGHT;

EID: 85009517263     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2016-309981     Document Type: Article

References (26)

1. Avouac J, Airò P, Meune C, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 2010;37:2290-8.
2. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-93.
3. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study. Arthritis Rheum 2005;52:3792-800.
4. Lefèvre G, Dauchet L, Hachulla E, et al. Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. Arthritis Rheum 2013;65:2412-23.
5. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-4.
6. Galiè N, Rubin LJ, Hoeper M, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 2008;371:2093-100.
7. Kovacs G, Maier R, Aberer E, et al. Pulmonary arterial hypertension therapy May be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure. Arthritis Rheum 2012;64:1257-62.
8. Hachulla E, Launay D, Yaici A, et al., French PAH-SSc Network. Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome. Rheumatology 2010;49:940-4.
9. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013;62:D34-41.
10. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Heart J 2016;37:67-119.
11. Rosenkranz S, Gibbs JS, Wachter R, et al. Left ventricular heart failure and pulmonary hypertension. Eur Heart J 2016;37:942-54.
12. Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013;62:D42-50.
13. Coghlan JG, Denton CP, Grünig E, et al., DETECT study group. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 2014;73:1340-9.
14. Grünig E, Barner A, Bell M, et al. Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with Updated Commentary of the Cologne Consensus Conference 2011. Int J Cardiol 2011;154(Suppl 1): S3-12.
15. Dumitrescu D, Oudiz RJ, Karpouzas G, et al. Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing. PLoS ONE 2010;5:e14293.
16. Nagel C, Henn P, Ehlken N, et al. Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension. Arthritis Res Ther 2015;17:165.
17. Ciurzynski M, Bienias P, Irzyk K, et al. Exaggerated increase of exercise-induced pulmonary artery pressure in systemic sclerosis patients predominantly results from left ventricular diastolic dysfunction. Clin Res Cardiol 2013;102 (11):813-20.
18. Sun XG, Oudiz RJ, Hansen JE, et al. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001;104:429-35.
19. Yasunobu Y, Oudiz RJ, Sun XG, et al. End-tidal pCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 2005;127:1637-46.
20. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26:511-22.
21. Opitz CF, Blindt R, Blumberg F, et al. Pulmonary hypertension: hemodynamic evaluation. Updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol 2011;154:S13-19.
22. Rosenkranz S, Behr J, Ewert R, et al. Right heart catheterization in pulmonary hypertension. Dtsch Med Wochenschr 2011;136:2601-16.
23. Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation. 5th edn. Philadelphia: Lippincott Williams & Wilkins, 2012:154-81. Chapter 7.
24. Arena R, Lavie CJ, Milani RV, et al. Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review. J Heart Lung Transplant 2010;29:159-73.
25. Tolle JJ, Waxman AB, Van Horn TL, et al. Exercise-induced pulmonary arterial hypertension. Circulation 2008;118:2183-9.
26. Kovacs G, Maier R, Aberer E, et al. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med 2009;180:881-6.